rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
2
|
pubmed:dateCreated |
1989-10-12
|
pubmed:abstractText |
In this study we have examined the effects of TRH, thyroid hormones and dopamine on the rat anterior pituitary content of neuromedin U-like immunoreactivity. Oral administration of TRH (20 mg/100 g per day) to euthyroid animals evoked a fivefold increase in peptide content after 12 days of treatment. This effect was found to be dependent upon circulating levels of thyroid hormone, since administration of TRH to thyroidectomized animals failed to show a similar effect without simultaneous treatment with tri-iodothyronine. The possibility that the TRH-induced increase in anterior lobe neuromedin U content reflected alterations in prolactin secretion or synthetic rate was also examined. Treatment of euthyroid animals with a dopamine agonist and antagonist was, however, without effect. These results demonstrate a unique relationship between TRH and thyroid hormone levels in increasing the anterior lobe content of neuromedin U immunoreactivity.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Bromocriptine,
http://linkedlifedata.com/resource/pubmed/chemical/Dopamine Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Dopamine Antagonists,
http://linkedlifedata.com/resource/pubmed/chemical/Haloperidol,
http://linkedlifedata.com/resource/pubmed/chemical/Neuropeptides,
http://linkedlifedata.com/resource/pubmed/chemical/Thyroid Hormones,
http://linkedlifedata.com/resource/pubmed/chemical/Thyrotropin,
http://linkedlifedata.com/resource/pubmed/chemical/Thyrotropin-Releasing Hormone,
http://linkedlifedata.com/resource/pubmed/chemical/Thyroxine,
http://linkedlifedata.com/resource/pubmed/chemical/Triiodothyronine,
http://linkedlifedata.com/resource/pubmed/chemical/neuromedin U 8
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0022-0795
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
122
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
471-6
|
pubmed:dateRevised |
2005-11-17
|
pubmed:meshHeading |
pubmed-meshheading:2570117-Animals,
pubmed-meshheading:2570117-Bromocriptine,
pubmed-meshheading:2570117-Dopamine Agents,
pubmed-meshheading:2570117-Dopamine Antagonists,
pubmed-meshheading:2570117-Haloperidol,
pubmed-meshheading:2570117-Male,
pubmed-meshheading:2570117-Neuropeptides,
pubmed-meshheading:2570117-Pituitary Gland, Anterior,
pubmed-meshheading:2570117-Rats,
pubmed-meshheading:2570117-Rats, Inbred Strains,
pubmed-meshheading:2570117-Thyroid Hormones,
pubmed-meshheading:2570117-Thyrotropin,
pubmed-meshheading:2570117-Thyrotropin-Releasing Hormone,
pubmed-meshheading:2570117-Thyroxine,
pubmed-meshheading:2570117-Triiodothyronine
|
pubmed:year |
1989
|
pubmed:articleTitle |
The anterior pituitary content of neuromedin U-like immunoreactivity is altered by thyrotrophin-releasing hormone and thyroid hormone status in the rat.
|
pubmed:affiliation |
Department of Medicine, Royal Postgraduate Medical School, Hammersmith Hospital, London.
|
pubmed:publicationType |
Journal Article
|